High Tide Inc. filings document its disclosures as a Canadian foreign issuer operating in cannabis retail, e-commerce accessories, hemp-derived CBD and international medical cannabis distribution. Form 6-K reports furnish company news releases covering Canna Cabana store activity, operating and financial results, subsidiary developments, insider share purchases, common-share trading matters, and financing arrangements.
The filing record also includes governance and compensation materials, including an amended statement of executive compensation. High Tide disclosures address its common-share capital structure, senior credit arrangements, executive and director compensation, board and management oversight, ownership information, material events, and risk-related topics connected to regulated cannabis markets in Canada, the United States and Germany.
High Tide Inc. is expanding its Canadian retail footprint by agreeing to acquire four Northern Helm cannabis stores in Ontario for $7.74 million. The locations in Bowmanville, Kingston, Courtice, and Oshawa will bring its network to 228 Canna Cabana stores across Canada and 103 in Ontario.
The arm's length deal involves assumed debt with a 2% interest rate plus a mix of cash and High Tide common shares, issued at a price based on a 10-day volume-weighted average with a floor tied to the TSX Venture Exchange’s Discounted Market Price. The purchase price equates to 4.5x the annualized Adjusted EBITDA of the acquired stores for the three months ended March 31, 2026.
Closing in the coming weeks is subject to approvals from the TSX Venture Exchange and the Alcohol and Gaming Commission of Ontario, as well as customary conditions. Management highlights this acquisition as part of a strategy to add cash-flowing assets, build a network of more than 350 stores over time, and complement growth in its German medical cannabis distribution business.
High Tide Inc. reported that it has opened a new Canna Cabana retail cannabis store in Welland, Ontario and expects to open another in Calgary, Alberta. The Welland store begins sales on June 10, 2026, while the Calgary location is expected to start on June 26, 2026, pending regulatory approval. These additions bring the Canna Cabana network to 224 stores across Canada, including 99 in Ontario and 92 in Alberta. Management highlights these locations as high-traffic, low-competition trade areas that support its discount club retail model and membership-focused growth strategy.
High Tide Inc. has filed a Form 6-K announcing when it will release financial and operational results for its second fiscal quarter of 2026. The results for the quarter ended April 30, 2026 will be issued after markets close on June 15, 2026 and posted on SEDAR+, EDGAR, and the company’s website.
The company will host a webcast on June 16, 2026 at 11:30 a.m. Eastern Time with its CEO and CFO to discuss the quarter and the remainder of the fiscal year. High Tide is also granting 66,500 incentive stock options to employees, exercisable for three years and vesting over two years under its Omnibus Plan.
High Tide Inc. is expanding its retail footprint with a new Canna Cabana cannabis store in Toronto’s Rexdale neighbourhood. The store at 150 Silver Reign Drive is expected to begin selling recreational cannabis and accessories for adult use on May 17, 2026.
This opening brings Canna Cabana’s footprint to 222 stores across Canada, including 98 locations in Ontario. Management highlights the site’s position in a busy power centre serving more than 263,000 residents within five kilometres, and frames the move as part of a disciplined, profitability-focused growth strategy in Canada’s largest cannabis market.
High Tide Inc. reported that certain officers, directors and consultants, led by its President and CEO, bought a total of 90,882 common shares on the open market between May 6 and May 8, 2026, at an average price of $3.39 per share. Following these purchases, insiders and certain consultants together own or control 7,720,360 common shares, representing about 8.8% of issued and outstanding shares. Management linked the buying to confidence in the company’s growth prospects, highlighting a $40 million senior lending credit facility term sheet with a Big 5 Canadian bank, record quarterly medical cannabis distribution volumes at Remexian, and Remexian’s German market share rising to over 14%.
High Tide Inc. reported that its 51%-owned German subsidiary, Remexian Pharma GmbH, sold 7.6 tonnes of medical cannabis into the German market in the quarter ended April 30, 2026, the highest quarterly distribution volume in its history.
The tonnage grew 21% sequentially and 49% year over year, supporting the company’s view that Germany is a key growth market and a platform for broader European expansion. Management links this performance to combining Remexian’s German distribution platform with High Tide’s Canadian procurement scale.
The company emphasized that these tonnage figures are preliminary and unaudited, may be revised when full second fiscal quarter 2026 financial statements are prepared, and should not replace the complete results, which are expected to be reported in June 2026.
High Tide Inc. has signed a term sheet with one of Canada's Big 5 chartered banks for new senior secured credit facilities totaling $40 million. The package includes a $25 million revolving facility with a three-year term and a $15 million delayed draw term loan with seven-year amortization.
On closing, the revolver is expected to refinance a little over $6 million owed to connectFirst Credit Union, leaving almost $19 million of additional revolver capacity. The delayed draw term loan is intended to refinance existing $15 million second-lien debentures. Interest will range between Prime + 2% and Prime + 3%, depending on leverage, with financial covenants tied to debt-to-EBITDA and fixed charge coverage tests. Closing is expected within 60 days, subject to customary conditions.
High Tide Inc. filed an amended statement of executive compensation for the year ended October 31, 2025, correcting omissions and errors in its prior disclosure and updating finalized annual incentive payouts.
The filing details the company’s pay philosophy, use of a cannabis‑sector peer group, and a three-part program of salary, discretionary cash bonuses, and long-term equity under a 20% fixed Omnibus Plan. In 2025, CEO Harkirat (Raj) Grover received salary of $825,000, a bonus of $1,056,000 and share-based awards of $1,540,111, for total compensation of $3,382,845. Across executives and directors, 708,164 RSUs were granted, and outstanding options and RSUs feature broad change-of-control vesting and severance protections.
High Tide Inc. is responding to investor concerns about unusual trading in its common shares. The company says it has observed, over more than ten consecutive quarters, that its strong earnings results often spark positive after-hours reactions, yet the next regular-session closing price frequently falls below the prior close.
Management and the board, working with the company’s market maker, have been reviewing trading data and now believe some activity may not reflect normal market forces and may be contrary to securities laws. High Tide plans to hire forensic investigators and trading‑surveillance specialists to review trading around earnings and other material news, and expects to share their findings with Canadian and U.S. regulators.
The company invites shareholders and market participants with relevant information to contact its investor relations team. High Tide highlights its cannabis retail and medical operations, including 221 Canna Cabana locations and a 12% share of the Canadian market, along with its German medical cannabis distributor Remexian Pharma.